주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Thursday, Aprill 25, 2024, 17:42
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Samsung Bioepis Earns European License for Autoimmune Disease Drug
Michael Herh
2024.04.24 12:27
[Yuhan] First data update since last October
Pyeongkuk Park
2024.03.26 08:34
Samsung Bioepis Receives European Recommendation for Stelara Biosimilar Pyzchiva
Choi Mun-hee
2024.02.26 08:32
Samsung Biologics Collaborates with LegoChem Biosciences on ADC Therapeutic Development
Jasmine Choi
2024.02.08 14:13
[Yuhan Corp] Internal sales estimate for amivantamab+lazertinib combo twice as high as consensus
Pyeongkuk Park
2023.12.07 15:39
[Yuhan Corp] MARIPOSA proves feasibility of first-line treatment
Pyeongkuk Park
2023.10.25 09:49
Samsung Bioepis, Celltrion Both Confirm Efficacy of Stelara Biosimilars
Jung Min-hee
2023.10.13 11:26
Spot Comment/Yuhan - Five things to watch for after phase III MARIPOSA success
Pyeongkuk Park
2023.10.04 22:13
The next Yuhan
Seungyeon Han
2023.09.27 15:09
Yuhan Corp. to Collaborate with Cyrus Therapeutics
Michael Herh
2023.09.06 18:49
Celltrion Completes Application for Stelara Biosimilar CT-P43 in Australia
Jasmine Choi
2023.09.01 15:32
Earnings beat consensus, but this is just the start
Pyeongkuk Park
2023.07.31 18:33
처음
1
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기